Skip to content

FMT in Gut aGVHD Treated

Department of Hematology of First Affiliated Hospital of Soochow University

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03148743
Enrollment
50
Registered
2017-05-11
Start date
2017-05-16
Completion date
2025-12-31
Last updated
2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-graft-versus-host Disease

Brief summary

With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.

Interventions

fecal microbiota transplantation

Sponsors

The First Affiliated Hospital of Soochow University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* gut GVHD

Exclusion criteria

* Age\>60; or Age\<10

Design outcomes

Primary

MeasureTime frameDescription
times of stool24hours,48hours,72hours, 96hours,fifth day,sixth day, a weekChange from stool times in a week

Secondary

MeasureTime frameDescription
volume in milliliter of stool24hours,48hours,72hours, 96hours,fifth day,sixth day, a weekChange from stool volume in a week

Countries

China

Contacts

Primary Contactxiaofei qi
qixiaofei@suda.edu.cn1-86-512-67780410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026